Atención médica de calidadDescubra por qué Mayo Clinic es el mejor lugar para atenderse. Pide una cita.
The clinical and translational research conducted by Shounak Majumder, M.D., focuses on early detection of pancreatic cancer. Dr. Majumder's research aims to develop a blood-based liquid biopsy test for early detection of pancreatic cancer in different at-risk patient groups.
In preliminary studies, Dr. Majumder's research group has identified novel methylated DNA biomarkers in pancreatic tissue that are highly associated with pancreatic cancer. His team is actively engaged in developing these diagnostic molecular biomarker tests in blood, pancreatic juice and cyst fluid, with the aim of accurately detect advanced pre-cancer and early-stage pancreatic cancer. Prospective studies to validate early results for these biomarkers are currently underway at Mayo Clinic.
Dr. Majumder is also leading a team of researchers developing artificial intelligence (AI)-based tools for early detection of pancreatic cancer.
Dr. Majumder's goal of discovery and validation of molecular biomarkers for early detection of pancreatic cancer will result in better outcomes for patients. Earlier detection of pancreatic cancer results in more-effective treatment and better survival rates. Dr. Majumder also leads the High-Risk Pancreas Clinic at Mayo Clinic, a highly specialized clinic for pancreatic cancer screening and surveillance in individuals with a genetic or familial predisposition to pancreatic cancer.
Infórmate sobre los ensayos clínicos que abordan preguntas científicas específicas sobre la salud humana y las enfermedades.
Ver mis estudios.
Explora todos los estudios de investigación en Mayo Clinic.
Ver las conclusiones revisadas por colegas que publiqué como resultado de mi investigación.